Advertisement
Screener

Axogen, Inc. (AXGN) Cash and Cash Equivalents, Period Increase (Decrease)

3.2 / 5 stars · 63/98 Roast Me

Axogen, Inc. Cash and Cash Equivalents, Period Increase (Decrease)

Axogen, Inc. (AXGN) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$10.88 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-29.

Discontinued › Cash Flow

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-10-29

  • Axogen, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$107.93M.
  • Axogen, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $103.00M.
  • Axogen, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$5.95M.
  • Axogen, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $14.47M, a 3.24% increase year-over-year.
  • Axogen, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $6.49M, a 58.16% increase from fiscal 2016.
  • Axogen, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $4.10M, a 76.80% decline from fiscal 2015.
  • Axogen, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $17.69M.
  • Axogen, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$11.85M, a 292.36% decline from fiscal 2013.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 6 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2018-09-30-$107.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29
-$4.93M
derived: sum of 2 quarters · filed 2018-10-29
-$10.88M
10-Q · filed 2018-10-29
$3.59M
derived: sum of 4 quarters · filed 2018-10-29
2018-06-30$103.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$97.06M
10-Q · filed 2018-08-01
$111.52M
derived: sum of 3 quarters · filed 2018-08-01
$109.69M
derived: sum of 4 quarters · filed 2018-10-29
2018-03-31-$5.95M
10-Q · filed 2018-04-30
$8.52M
derived: sum of 2 quarters · filed 2018-04-30
$6.69M
derived: sum of 3 quarters · filed 2018-10-29
$4.65M
derived: sum of 4 quarters · filed 2018-10-29
2017-12-31$14.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$12.64M
derived: sum of 2 quarters · filed 2018-10-29
$10.59M
derived: sum of 3 quarters · filed 2018-10-29
$6.49M
10-K · filed 2018-02-28
2017-09-30-$1.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29
-$3.87M
derived: sum of 2 quarters · filed 2018-10-29
-$7.97M
10-Q · filed 2018-10-29
$6.04M
derived: sum of 4 quarters · filed 2018-10-29
2017-06-30-$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
-$6.14M
10-Q · filed 2018-08-01
$7.87M
derived: sum of 3 quarters · filed 2018-08-01
$5.60M
derived: sum of 4 quarters · filed 2018-08-01
2017-03-31-$4.10M
10-Q · filed 2018-04-30
$9.91M
derived: sum of 2 quarters · filed 2018-04-30
$7.64M
derived: sum of 3 quarters · filed 2018-04-30
$4.97M
derived: sum of 4 quarters · filed 2018-04-30
2016-12-31$14.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$11.74M
derived: sum of 2 quarters · filed 2018-02-28
$9.07M
derived: sum of 3 quarters · filed 2018-02-28
$4.10M
10-K · filed 2018-02-28
2016-09-30-$2.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
-$4.95M
derived: sum of 2 quarters · filed 2017-11-01
-$9.91M
10-Q · filed 2017-11-01
-$13.93M
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30-$2.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$7.64M
10-Q · filed 2017-08-02
-$11.66M
derived: sum of 3 quarters · filed 2018-02-28
$2.65M
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31-$4.96M
10-Q · filed 2017-05-04
-$8.99M
derived: sum of 2 quarters · filed 2018-02-28
$5.33M
derived: sum of 3 quarters · filed 2018-02-28
$1.69M
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31-$4.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$10.29M
derived: sum of 2 quarters · filed 2018-02-28
$6.65M
derived: sum of 3 quarters · filed 2018-02-28
$17.69M
10-K · filed 2018-02-28
2015-09-30$14.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$10.68M
derived: sum of 2 quarters · filed 2016-11-02
$21.72M
10-Q · filed 2016-11-02
$18.13M
derived: sum of 4 quarters · filed 2016-11-02
2015-06-30-$3.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$7.41M
10-Q · filed 2016-08-03
$3.82M
derived: sum of 3 quarters · filed 2016-08-03
$1.45M
derived: sum of 4 quarters · filed 2016-08-03
2015-03-31$11.04M
10-Q · filed 2016-05-04
$7.45M
derived: sum of 2 quarters · filed 2016-05-04
$5.09M
derived: sum of 3 quarters · filed 2016-05-04
$2.45M
derived: sum of 4 quarters · filed 2016-05-04
2014-12-31-$3.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$5.95M
derived: sum of 2 quarters · filed 2016-02-29
-$8.59M
derived: sum of 3 quarters · filed 2016-02-29
-$11.85M
10-K · filed 2016-02-29
2014-09-30-$2.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$5.01M
derived: sum of 2 quarters · filed 2015-11-05
-$8.27M
10-Q · filed 2015-11-05
-$10.78M
derived: sum of 4 quarters · filed 2015-11-05
2014-06-30-$2.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$5.90M
10-Q · filed 2015-08-06
-$8.42M
derived: sum of 3 quarters · filed 2015-08-06
$5.48M
derived: sum of 4 quarters · filed 2015-08-06
2014-03-31-$3.26M
10-Q · filed 2015-05-05
-$5.78M
derived: sum of 2 quarters · filed 2015-05-05
$8.12M
derived: sum of 3 quarters · filed 2015-05-05
$5.61M
derived: sum of 4 quarters · filed 2015-05-05
2013-12-31-$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05
$11.38M
derived: sum of 2 quarters · filed 2015-03-05
$8.87M
derived: sum of 3 quarters · filed 2015-03-05
$6.16M
10-K · filed 2015-03-05
2013-09-30$13.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$11.39M
derived: sum of 2 quarters · filed 2014-11-13
$8.68M
10-Q · filed 2014-11-13
$18.14M
derived: sum of 4 quarters · filed 2014-11-13
2013-06-30-$2.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04
-$5.21M
10-Q · filed 2014-08-04
$4.25M
derived: sum of 3 quarters · filed 2014-08-04
$4.05M
derived: sum of 4 quarters · filed 2014-08-04
2013-03-31-$2.71M
10-Q · filed 2014-04-30
$6.76M
derived: sum of 2 quarters · filed 2014-04-30
$6.56M
derived: sum of 3 quarters · filed 2014-04-30
$5.56M
derived: sum of 4 quarters · filed 2014-04-30
2012-12-31$9.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06
$9.27M
derived: sum of 2 quarters · filed 2014-03-06
$8.27M
derived: sum of 3 quarters · filed 2014-03-06
$5.72M
10-K · filed 2014-03-06
2012-09-30-$193.69K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
-$1.20M
derived: sum of 2 quarters · filed 2013-10-30
-$3.75M
10-Q · filed 2013-10-30
-$6.08M
derived: sum of 4 quarters · filed 2013-10-30
2012-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$3.55M
10-Q · filed 2013-08-14
-$5.89M
derived: sum of 3 quarters · filed 2013-08-14
$2.41M
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31-$2.55M
10-Q · filed 2013-04-30
-$4.88M
derived: sum of 2 quarters · filed 2013-08-07
$3.41M
derived: sum of 3 quarters · filed 2013-08-07
$5.06M
derived: sum of 4 quarters · filed 2013-08-07
2011-12-31-$2.33M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07
$5.96M
derived: sum of 2 quarters · filed 2013-08-07
$7.60M
derived: sum of 3 quarters · filed 2013-08-07
$6.39M
10-K/A · filed 2013-08-07
2011-09-30$8.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
$9.94M
derived: sum of 2 quarters · filed 2012-11-06
$8.73M
10-Q · filed 2012-11-06
$10.32M
derived: sum of 4 quarters · filed 2012-11-06
2011-06-30$1.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$430.72K
10-Q · filed 2012-08-14
$763.50K
10-Q/A · filed 2011-09-09
$2.02M
derived: sum of 3 quarters · filed 2012-08-14
$8.08M
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31-$1.21M
10-Q · filed 2012-05-15
$379.41K
derived: sum of 2 quarters · filed 2012-05-15
$6.44M
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$1.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15
$7.65M
derived: sum of 2 quarters · filed 2012-03-15
$1.52M
10-K · filed 2012-03-15
2010-09-30$6.06M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14
-$75.47K
10-Q · filed 2011-11-14
2010-06-30-$6.13M
10-Q/A · filed 2011-09-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53